Vivaldi, A <br/><br/>
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.  [electronic resource] 

 -  Molecular and cellular endocrinology  May 2012 
 - 41-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8057 
<br/><br/><label>Standard No.: </label>10.1016/j.mce.2012.01.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--antagonists & inhibitors<br/>Apoptosis--drug effects<br/>Carcinoma, Neuroendocrine<br/>Celecoxib<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cyclooxygenase 2--metabolism<br/>Cyclooxygenase 2 Inhibitors--pharmacology<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Gene Expression<br/>Humans<br/>Pyrazoles--pharmacology<br/>RNA, Messenger--biosynthesis<br/>Sulfonamides--pharmacology<br/>Thyroid Neoplasms--drug therapy<br/>Vinblastine--analogs & derivatives<br/>Vinorelbine